Renal Disease: Drug Dosing and Drug‑Induced Nephrotoxicity
- DIR Index
- Basic and Pharmaceutical Sciences
- Clinical Specialties
- Athletes' Precautions and Banned Drugs
- Bioterrorism and Disaster Planning
- Cancer
- Cardiology
- Clinical Practice Guidelines
- CNS Disorders
- Dermatology
- Emergency Medicine
- Endocrine Disorders
- Gastroenterology
- Geriatric Patients
- Gynecology
- Health Technology Assessment
- Hepatic Disease and Hepatotoxicity
- Laboratory Medicine
- LGBTQ+ Resources
- Infectious Disease
- Natural Medicines
- Neonatology
- Nutrition
- Obesity
- Oncology
- Pain Management/Palliative Care
- Pediatric Patients
- Psychopharmacology
- Pregnant or Lactating Patients
- Renal Disease: Drug Dosing and Drug-Induced Nephrotoxicity
- Reproductive Health
- Respirology
- Substance Use/Substance Related Disorders
- Drug-Related Resources
- Evidence Based Resources
- Health Administration and Systems
- Pharmacy Learning and Teaching
- Pharmacy Practice
Websites
Websites for Health Professionals
- 2014 Dialysis of Drugs (PDF) - $
- Chronic Kidney Disease Resource Center (Medscape, registration required)
- Cochrane Renal Reviews (Cochrane Renal Group)
- Hypertension, Dialysis and Clinical Nephrology
- National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
- Real Pharmacists Network
Professional Organizations
- Canadian Diabetes Association
- International Society for Peritoneal Dialysis
- Kidney Foundation of Canada
- National Kidney Foundation
- Journal of International Society of Nephrology (Kidney International)
Professional Organizations - Guidelines and Policy Statements
- Canadian Diabetes Association Clinical Practice Guidelines
- Canadian Society of Nephrology Hemodialysis Clinical Practice Guidelines (2006)
- Canadian Society of Nephrology Clinical Practice Guidelines for the Management of Anemia Associated with Chronic Kidney disease (2008)
- Guidelines for the management of chronic kidney disease
- National Kidney Foundation Kidney Disease Outcomes Quality Initiative (NKF KDOQI)
- National Kidney Foundation KDOQI Guidelines and Commentaries
Clinical Practice Guidelines
General
- Canadian Diabetes Association Clinical Practice Guidelines
- Canadian Society of Nephrology Hemodialysis Clinical Practice Guidelines [PDF] (2006)
- Canadian Society of Nephrology Clinical Practice Guidelines for the Management of Anemia Associated with Chronic Kidney Disease [PDF] (2008)
- Guidelines For Management of Chronic Kidney Disease (Canadian Society of Nephrology)
- National Kidney Foundation KDOQI Guidelines and Commentaries (NKF KDOQI)
Resources
Drug Dosing in Renal Disease
- Kidney Disease Program
- Drug Dosing Adjustments in Patients with Chronic Kidney Disease
- Drug Prescribing in Renal Failure: Dosing Guidelines for Adults and Children (5th ed. 2007) - $
- The Renal Drug Handbook (Ashley & Currie, 4th ed. 2014) - $
- WHO Model Formulary 2008 (PDF)
- see Appendix IV: Renal Impairment
Infectious Disease
- Dialysis Event Protocol [PDF] (Centers for Disease Control and Prevention 2018)
- Guidelines for Vaccinating Kidney Dialysis Patients & Patients with Chronic Kidney Disease [PDF] (Centers for Disease Control and Prevention)
Patient Decision Aids
- Patient Decision Aids (Ottawa Hospital Research Institute)
Predicting Creatinine Clearance and GFR
- GFR Calculators (National Kidney Disease Education Program)
Print and Electronic Resources
*Recommended texts & electronic resources are linked to publishers' or book sellers' websites for further ordering information
- Applied Therapeutics: The Clinical Use of Drugs (Koda-Kimble et al. 10th ed. 2012) - $
- see Chapter 34: Dosing of Drugs in Renal Failure
- Brenner and Rector's The Kidney (10th ed. 2016) - $
- see Chapter 57: Prescribing Drugs in Kidney Disease
- Clinical Nephrotoxins: Renal Injury From Drugs and Chemicals (Broe & Porter, 3rd ed 2008) - $
- Introduction to Renal Therapeutics (Ashley & Morlidge, 2008) - $
- Pharmacotherapy: A Pathophysiologic Approach (DiPiro et al. 9th ed. 2014) - $
- see Chapter 49: Drug-Induced Kidney Disease
- see Chapter 51: Drug Therapy Individualization for Patients with Renal Insufficiency
- Primer on Kidney Diseases (Greenberg, 6th ed. 2014) - $
- see Chapter 34: Kidney Failure Due to Therapeutic Agents
- see Chapter 39: Analgesics and the Kidney
- see Chapter 40: Principles of Drug Therapy in Kidney Failure
- Seldin and Giebisch's The Kidney: Physiology & Pathophysiology (Alpern & Hebert, 5th ed. 2013) - $
- see Chapter 87: Cellular Mechanisms of Drug Nephrotoxicity
- see Chapter 98: Disposition and Dose Requirements of Drugs in Renal Insufficiency
- see Chapter 101: Cellular Mechanism of Drug Nephrotoxicity
- see Chapter 104: Disposition and Dose Requirements of Drugs in Renal Insufficiency
- Textbook of Therapeutics: Drug and Disease Management (Helms & Quan, 8th ed. 2006) - $
- see Chapter 44: Dialysis Options and Pharmacotherapy for End-Stage Renal Disease
- The APhA Complete Review for Pharmacy (Chyka, 11th ed. 2015) - $
- see Chapter 20: Kidney Disease
- The Merck Manual of Diagnosis and Therapy (20th ed. 2018, also available online)
- see Chapter 226: Toxic Nephrology
- Therapeutic Choices (CPhA, 2019) - $
- see CTC: Dosage Adjustment in Renal Impairment
Renal Patient Resources
- Diabetes and Kidney Disease (Canadian Diabetes Association)
- Kidney Foundation of Canada
- National Kidney Foundation
- Patient Resources (Renal Pharmacists Network)
- Chronic Kidney Disease Patient Handbook (CAN-Solve)
Videos for Patients
- Failing Kidneys and Different Treatment Options (DocMikeEvans)
Published: 01 Jun 2015
Revised: 11 Nov 2019